MedTrace Logo

Treatment of Femoro-popliteal Atherosclerotic Lesions Using the Ranger Paclitaxel Coated Balloon Catheter. All Comers Registry.

NCT02462005 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 171

Last updated 2020-01-09

No results posted yet for this study

Summary

A total of up to 250 patients from an all-comers patient population with infrainguinal atherosclerotic disease who are implanted or scheduled for an implant with a Ranger Drug coated balloon.

Interim analysis will be carried out for every 50 subjects enrolled.

Conditions

  • Atherosclerotic Disease

Sponsors & Collaborators

  • Boston Scientific Corporation

    collaborator INDUSTRY

  • Klinikum Arnsberg

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2018-06-30
Completion
2019-05-31

Countries

  • Germany
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02462005 on ClinicalTrials.gov